| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sionna Therapeutics, Inc. | Chief Medical Officer | Non-Qualified Stock Option (right to buy) | 155,700 | 02 Jan 2026 | Direct | ||
| Sionna Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 148,536 | 06 Feb 2025 | Direct | ||
| Sionna Therapeutics, Inc. | Chief Medical Officer | Common Stock | 28,415 | 06 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SION | Sionna Therapeutics, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Chief Medical Officer | 06 Jan 2026, 16:26 |
| SION | Sionna Therapeutics, Inc. | 06 Feb 2025 | 1 | $0 | 4 | Chief Medical Officer | 10 Feb 2025, 16:05 |
| SION | Sionna Therapeutics, Inc. | 06 Feb 2025 | 0 | $0 | 3 | Chief Medical Officer | 06 Feb 2025, 21:18 |